TET2 and myeloproliferative neoplasm: In recent studies, along with JAK2V617F, a coexisting Ten-Eleven Translocation-2 (TET2) gene, loss-of-function mutation has been found in the minimal loss of heterozygosity region of chromosome 4q24 in MPN patients [2].